December 28, 2009
Email Received December 28, 2009: Good day May I use the spirit of this season to introduce myself to you and at the same time introduce my intentions to you? I am Mr. Robert Duke one of the portfolio funds managers of The Scottish Investment Trust Plc. The largest and oldest Independent self managed funds Management Company in the United Kingdom with over £450 billion Capital Investment Funds. Nevertheless, as a Scottish Investment Funds Manager, I handle all our Investor’s Direct Capital Funds and extracted 1.3% Excess Maximum Return Capital Profit (EMRCP) per annum on each of the Investor’s Magellan Capital Funds. As an expert, I have made over £45.500,000.00 million from the Investor’s EMRCP and hereby looking for someone to trust who will stand as an Investor to receive the funds as Annual Investment Proceeds from Scottish Magellan Capital Funds. All confirmable documents to back up the claims will be made available to you accordingly. Meanwhile, I have worked out the strategies and technicalities whereby the funds can be claimed in any of our Clearing Houses without any hitches. Furthermore, 40% of the total funds will be for you as the foreign partner, 10% will go to charity organization, while 50% will be mine as the initiator of the deal. If you are interested, Please email me for discussion of this transaction in detail. Yours sincerely Robert
Read the full article →
December 10, 2009
Well, sort of. You can wait until the end of the term to hear oral argument in Bilski v. Kappos, or you can listen to Professor Doug Lichtman’s students’ impassioned reading of the transcript, on the superb Intellectual Property Colloquium. I found this reading to be very accessible – a new twist on audiobooks. IP Colloquium is by far my favorite legal podcast. Professor Lichtman has great guests and provides thoughtful commentary. This Shakespearean treatment of an appeal hearing is inspired. (Nice summary of the background of Bilski, and what’s at issue, on Bill Trout’s blog). And, some nice quotes from the justices, trying to figure out the limits of patent protection. Could a patent protect – “somebody who writes a book on how to win friends and influence people?””horse whisperers?””a method for speed dating?” “a great wonderful, really original method of teaching antitrust law?” “actuarial tables and risk formulas?” In the meantime the CAFC is applying its “machine or transformation” test from its en banc ruling in In re Bilski. A recent example of this is Prometheus Labs v. Mayo, issued on September 16, 2009, where the patentable invention was a “pro-drug that upon administration to a patient converts to 6M-P, which are used to treat inflammatory bowel diseases (“IBD”) such as Crohn’s disease and ulcerative colitis.” The CAFC held, among other things, that patent law does protect the…
Read the full article →